SYNDESI THERAPEUTICS
De berekende faillissementskans van SYNDESI THERAPEUTICS over 12 maanden bedraagt 0,4% (zeer laag). Het bedrijf is actief sinds 2017 en het Belgisch Staatsblad bevat geen insolventie- of waarschuwingssignalen. Er zijn geen verwerkte jaarrekeningcijfers beschikbaar; deze conclusie steunt uitsluitend op register- en Staatsbladgegevens.
| Actief | 8 jaar |
| Bestuur | 5 |
| Vestigingen | 1 |
| Publicaties | 65 |
Statistische inschatting op basis van openbare bronnen — geen kredietadvies of vaststelling. Hoe berekenen we dit?
| Boekjaar | Type | Neerlegging | Referentie |
|---|---|---|---|
| 31-12-2025 | volledig | 08-06-2026 | 2026-00155848 |
| 31-12-2024 | volledig | 17-06-2025 | 2025-00153650 |
| 31-12-2023 | micro | 22-07-2024 | 2024-00271132 |
| 31-12-2022 | micro | 12-10-2023 | 2023-00486281 |
| 31-12-2021 | micro | 25-07-2022 | 2022-20217401 |
| 31-12-2020 | micro | 10-06-2021 | 2021-19600581 |
| 31-12-2019 | micro | 26-06-2020 | 2020-20700493 |
| 31-12-2018 | micro | 28-05-2019 | 2019-14500277 |
-
Actief01-12-2025 → heden
-
Actief25-02-2022 → heden
-
JCO Consulting SRLRechtspersoonBestuurder· vast vert.: Jean CombalbertStaatsblad-akte 21086769 (19-07-2021)Actief19-07-2021 → heden
-
AMRON NEUROSCIENCE LLCRechtspersoonBestuurder· vast vert.: Roy Ervin TwymanStaatsblad-akte 21086769 (19-07-2021)Actief26-10-2018 → heden
2 gebeurtenissen
- 19-07-2021 Mandaat verlengd· Bestuurder
- 26-10-2018 Benoemd· Bestuurder
-
Actief05-02-2018 → heden
Voormalige bestuurders (9)
-
Voormalig25-02-2022 → 01-12-2025
2 gebeurtenissen
- 01-12-2025 Ontslagen· Bestuurder
- 25-02-2022 Benoemd· Bestuurder
-
Voormalig01-12-2022 → 21-11-2024
2 gebeurtenissen
- 21-11-2024 Ontslagen· Bestuurder
- 01-12-2022 Benoemd· Bestuurder
-
Voormalig25-02-2022 → 01-12-2022
2 gebeurtenissen
- 01-12-2022 Ontslagen· Bestuurder
- 25-02-2022 Benoemd· Bestuurder
-
Voormalig05-02-2018 → 25-02-2022
2 gebeurtenissen
- 25-02-2022 Ontslagen· Bestuurder
- 05-02-2018 Benoemd· Bestuurder
-
Voormalig05-02-2018 → 25-02-2022
2 gebeurtenissen
- 25-02-2022 Ontslagen· Bestuurder
- 05-02-2018 Benoemd· Bestuurder
-
Voormalig05-02-2018 → 25-02-2022
2 gebeurtenissen
- 25-02-2022 Ontslagen· Bestuurder
- 05-02-2018 Benoemd· Bestuurder
-
Voormalig30-09-2020 → 25-02-2022
2 gebeurtenissen
- 25-02-2022 Ontslagen· Bestuurder
- 30-09-2020 Benoemd· Bestuurder
-
Voormalig— → 25-02-2022
-
Voormalig31-07-2019 → 30-09-2020
2 gebeurtenissen
- 30-09-2020 Ontslagen· Bestuurder
- 31-07-2019 Benoemd· Bestuurder
| Commissaris / bedrijfsrevisor | IBR/IRE-nummer | Periode |
|---|---|---|
| BDO Réviseurs d'Entreprises SCRLActief Commissaris · vertegenwoordigd door Veerle Catry |
— | 19-07-2021 → heden |
| NACE primair | 72101 |
| Rechtsvorm | NV(014) |
| Oprichtingsdatum | 19-12-2017 |
| Status | Actief |
| Postcode | 1300 |
Percelen gekoppeld aan dit bedrijf via zijn adressen in de KBO (zetel, vestigingen, bijkantoren), gekruist met het kadastraal percelenplan. Dit toont waar het bedrijf actief is — geen eigendomsregister.
| Perceel (capakey) | Regio | Oppervlakte | Gebouwen | Hoogte / verd. |
|---|---|---|---|---|
| 25112N0041/00B000 | Wallonië | 1,5 ha | 1 · 832 m² | 21,3 m · 6 verd. |
Eén tijdlijn van alles wat er met dit bedrijf is gebeurd — publicaties, insolventie- en levensloopgebeurtenissen, administratieve wijzigingen en neergelegde jaarrekeningen.
07-05-2026 1 bestuurder benoemd, 1 ontslagnemend
- Erica Silbiger — Bestuurder
- Rolfe van de Spreng — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Rolfe van de Spreng",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_dissolution",
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": false,
"effective_date": "2026-04-01",
"evidence_quote": "II ressort des r\u00E9solutions \u00E9crites de l\u0027actionnaire unique en date du 1ier avril 2026 que l\u0027actionnaire unique a accept\u00E9 la d\u00E9mission de Rolfe van de Spreng \u00E0 compter du 1er avril 2026.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Erica Silbiger",
"address": "Avenue Einstein 14, 1300 Wavre",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": false,
"effective_date": "2026-04-01",
"evidence_quote": "L\u0027actionnaire unique a d\u00E9cid\u00E9 de nommer Erica Silbiger, \u00E9lisant domicile au si\u00E8ge de la Soci\u00E9t\u00E9, en qualit\u00E9 de nouvel administrateur de la Soci\u00E9t\u00E9, avec effet au 1er avril 2026.",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2027"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "decharge_granted",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Erica Silbiger",
"address": "Avenue Einstein 14, 1300 Wavre",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": false,
"effective_date": null,
"evidence_quote": "Son mandat ne sera pas r\u00E9mun\u00E9r\u00E9 et prendra fin imm\u00E9diatement lors de l\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire des actionnaires qui se tiendra en 2027.",
"decharge_status": "granted",
"mandate_duration": {
"kind": "until_agm_year",
"value": "2027"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2026-05-07",
"filing_date": null,
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2026-04-01",
"unanimous": true
},
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2026-04-01",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0686.599.355",
"name_full": "Syndesi Therapeutics",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Nathalie Boonen",
"org_rep_person_name": null,
"person_role_at_subject": "Mandataire sp\u00E9cial"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}07-05-2026 1 bestuurder benoemd, 1 ontslagnemend
- Erica Silbiger — Bestuurder
- Rolfe van de Spreng — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Rolfe van de Spreng",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Erica Silbiger",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "Syndesi Therapeutics"
}
}06-01-2026 1 bestuurder benoemd, 1 ontslagnemend
- Rolfe van de Spreng — Bestuurder
- Jean-Antoine de Los Frailes — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jean-Antoine de Los Frailes",
"address": null,
"birth_date": null
},
"effective_date": "2025-12-01",
"evidence_quote": "Il ressort des r\u00E9solutions prises par l\u0027actionnaire unique en date du 9 d\u00E9cembre 2025 que l\u0027actionnaire unique a accept\u00E9 la d\u00E9mission de M. Jean-Antoine de Los Frailes \u00E0 compter du 1ier d\u00E9cembre 2025."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Rolfe van de Spreng",
"address": null,
"birth_date": null
},
"effective_date": "2025-12-01",
"evidence_quote": "L\u0027actionnaire unique a nomm\u00E9 Rolfe van de Spreng, \u00E9lisant domicile au si\u00E8ge de la Soci\u00E9t\u00E9, en qualit\u00E9 de nouvel administrateur de la Soci\u00E9t\u00E9, avec effet au 1ier d\u00E9cembre 2025."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "SYNDESI THERAPEUTICS",
"legal_form": "SA"
}
}06-01-2026 1 bestuurder benoemd, 1 ontslagnemend
- Rolfe van de Spreng — Bestuurder
- Jean-Antoine de Los Frailes — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Jean-Antoine de Los Frailes",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_dissolution",
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": "2025-12-01",
"evidence_quote": "l\u0027actionnaire unique a accept\u00E9 la d\u00E9mission de M. Jean-Antoine de Los Frailes \u00E0 compter du 1ier d\u00E9cembre 2025.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Rolfe van de Spreng",
"address": "Avenue Einstein 14, 1300 Wavre",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": false,
"effective_date": "2025-12-01",
"evidence_quote": "L\u0027actionnaire unique a nomm\u00E9 Rolfe van de Spreng, \u00E9lisant domicile au si\u00E8ge de la Soci\u00E9t\u00E9, en qualit\u00E9 de nouvel administrateur de la Soci\u00E9t\u00E9, avec effet au 1ier d\u00E9cembre 2025.",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2027"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2026-01-06",
"filing_date": "2025-12-24",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2025-12-09",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0686.599.355",
"name_full": "Syndesi Therapeutics",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "org",
"org_kbo": null,
"org_name": "PwC Business Advisory Services SRL",
"person_name": null,
"org_rep_person_name": "Nathalie Boonen",
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}06-01-2026 1 bestuurder benoemd, 1 ontslagnemend
- Rolfe van de Spreng — Bestuurder
- Jean-Antoine de Los Frailes — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Jean-Antoine de Los Frailes",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Rolfe van de Spreng",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "Syndesi Therapeutics"
}
}23-12-2024 Scott Reents neemt ontslag als bestuurder
- Scott Reents — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Scott Reents",
"address": null,
"birth_date": null
},
"effective_date": "2024-11-21",
"evidence_quote": "Il ressort des r\u00E9solutions \u00E9crites prises par l\u0027actionnaire unique dd 26 novembre 2024 que l\u0027actionnaire unique a accept\u00E9 la d\u00E9mission de Monsieur Scott Reents \u00E0 compter du 21 novembre 2024."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "SYNDESI THERAPEUTICS",
"legal_form": "SA"
}
}23-12-2024 Scott Reents neemt ontslag als bestuurder
- Scott Reents — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Scott Reents",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "Syndesi Therapeutics"
}
}23-12-2024 3 ontslagnemend
- Scott Reents — Bestuurder
- Nathalie Boonen — Bestuurder
- Ward Van Aelst — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Scott Reents",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": "de_plein_droit_dissolution",
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": "2024-11-21",
"evidence_quote": "Il ressort des r\u00E9solutions \u00E9crites prises par l\u0027actionnaire unique dd 26 novembre 2024 que l\u0027actionnaire unique a accept\u00E9 la d\u00E9mission de Monsieur Scott Reents \u00E0 compter du 21 novembre 2024.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Nathalie Boonen",
"address": null,
"birth_date": null,
"profession": "employ\u00E9e de PwC Business Advisory Services SRL",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "PwC Business Advisory Services SRL",
"address": null,
"country": null,
"legal_form": "SRL"
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "Nathalie Boonen employ\u00E9e de PwC Business Advisory Services SRL et/ou Ward Van Aelst, employ\u00E9 de PwC Legal SRL, chacun d\u0027entre eux pouvant agir individuellement et avec pouvoir de substitution, ont \u00E9t\u00E9 charg\u00E9 de la signature et le d\u00E9p\u00F4t des formulaires I et II",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Ward Van Aelst",
"address": null,
"birth_date": null,
"profession": "employ\u00E9 de PwC Legal SRL",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "PwC Legal SRL",
"address": null,
"country": null,
"legal_form": "SRL"
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "Nathalie Boonen employ\u00E9e de PwC Business Advisory Services SRL et/ou Ward Van Aelst, employ\u00E9 de PwC Legal SRL, chacun d\u0027entre eux pouvant agir individuellement et avec pouvoir de substitution, ont \u00E9t\u00E9 charg\u00E9 de la signature et le d\u00E9p\u00F4t des formulaires I et II",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Scott Reents",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Nathalie Boonen",
"address": null,
"birth_date": null,
"profession": "employ\u00E9e de PwC Business Advisory Services SRL",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "PwC Business Advisory Services SRL",
"address": null,
"country": null,
"legal_form": "SRL"
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Ward Van Aelst",
"address": null,
"birth_date": null,
"profession": "employ\u00E9 de PwC Legal SRL",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "PwC Legal SRL",
"address": null,
"country": null,
"legal_form": "SRL"
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": "Ottignies-Louvain-la-Neuve",
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2024-12-23",
"filing_date": "2024-12-02",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2024-11-26",
"unanimous": true
},
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2024-11-26",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0686.599.355",
"name_full": "Syndesi Therapeutics",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Ward Van Aelst",
"org_rep_person_name": null,
"person_role_at_subject": "Mandataire"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}14-11-2024 2 bestuurders benoemd
- EY Réviseurs d'Entreprises SRL — Commissaire
- Thomas Meurice — Représentant permanent du commissaire
Technische details
{
"events": [
{
"kind": "director_in",
"role": "commissaire",
"person": {
"rrn": null,
"name": "EY R\u00E9viseurs d\u0027Entreprises SRL",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "repr\u00E9sentant permanent du commissaire",
"person": {
"rrn": null,
"name": "Thomas Meurice",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "Syndesi Therapeutics"
}
}14-11-2024 EY Réviseurs d'Entreprises SRL benoemd tot commissaris
- EY Réviseurs d'Entreprises SRL — Commissaris
Technische details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "EY R\u00E9viseurs d\u0027Entreprises SRL",
"address": null,
"birth_date": null
},
"evidence_quote": "II ressort des r\u00E9solutions prises par l\u0027actionnaire unique en date du 28 octrobre 2024 que l\u0027actionnaire unique a d\u00E9cid\u00E9 de nommer la soci\u00E9t\u00E9 \u00AB EY R\u00E9viseurs d\u0027Entreprises SRL \u00BB (B00160), ayant son si\u00E8ge \u00E0 Kouterveldstraat 7B, 1831 Diegem, comme commissaire de la Soci\u00E9t\u00E9 pour un terme de trois ans, s"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "SYNDESI THERAPEUTICS",
"legal_form": "SA"
}
}05-12-2023 Zetelverplaatsing van Louvain-La-Neuve naar Wavre
- Chemin du Cyclotron 6, 1348 Louvain-La-Neuve → Avenue Einstein 14, 1300 Wavre
Technische details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "Avenue Einstein 14, 1300 Wavre",
"city": "Wavre",
"region": "waals_gewest",
"street": "Avenue Einstein",
"country": "BE",
"postcode": "1300",
"box_number": null,
"street_number": "14",
"locality_suffix": null
},
"old_address": {
"raw": "Chemin du Cyclotron 6, 1348 Louvain-La-Neuve",
"city": "Louvain-La-Neuve",
"region": "waals_gewest",
"street": "Chemin du Cyclotron",
"country": "BE",
"postcode": "1348",
"box_number": null,
"street_number": "6",
"locality_suffix": null
},
"effective_date": "2023-10-31",
"evidence_quote": "les administrateurs ont d\u00E9cid\u00E9 de transf\u00E9rer le si\u00E8ge de la Soci\u00E9t\u00E9 et le si\u00E8ge d\u0027exploitation de Chemin du Cyclotron 6 1348 Louvain-La-Neuve \u00E0 Avenue Einstein 14, 1300 Wavre et ceci \u00E0 partir du 31 octobre 2023",
"region_changed": false,
"is_statute_change": false,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "retroactive",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
},
{
"kind": "zetel_transfer",
"seat_type": "unite_exploitation",
"new_address": {
"raw": "Avenue Einstein 14, 1300 Wavre",
"city": "Wavre",
"region": "waals_gewest",
"street": "Avenue Einstein",
"country": "BE",
"postcode": "1300",
"box_number": null,
"street_number": "14",
"locality_suffix": null
},
"old_address": {
"raw": "Chemin du Cyclotron 6, 1348 Louvain-La-Neuve",
"city": "Louvain-La-Neuve",
"region": "waals_gewest",
"street": "Chemin du Cyclotron",
"country": "BE",
"postcode": "1348",
"box_number": null,
"street_number": "6",
"locality_suffix": null
},
"effective_date": "2023-10-31",
"evidence_quote": "les administrateurs ont d\u00E9cid\u00E9 de transf\u00E9rer le si\u00E8ge de la Soci\u00E9t\u00E9 et le si\u00E8ge d\u0027exploitation de Chemin du Cyclotron 6 1348 Louvain-La-Neuve \u00E0 Avenue Einstein 14, 1300 Wavre et ceci \u00E0 partir du 31 octobre 2023",
"region_changed": false,
"is_statute_change": false,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "retroactive",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": "Nathalie Boonen",
"firm_city": null,
"firm_name": "PwC Business Advisory Services SRL / PwC Legal SRL",
"office_city": "Anvers",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2023-12-05",
"filing_date": "2023-11-02",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "raad_van_bestuur",
"date": "2023-11-19",
"unanimous": true
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "Syndesi Therapeutics",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Nathalje Boonen",
"org_rep_person_name": null,
"person_role_at_subject": "Mandataire sp\u00E9cial"
},
"co_filed_documents": [
"Formulaires I et II",
"Procuration pour le Guichet d\u0027Entreprises de Securex ASBL"
]
}05-12-2023 Zetelverplaatsing van Louvain-La-Neuve naar Wavre
- Chemin du Cyclotron 6, 1348 Louvain-La-Neuve → Avenue Einstein 14, 1300 Wavre
Technische details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "combined",
"new_address": {
"raw": "Avenue Einstein 14, 1300 Wavre",
"city": "Wavre",
"region": "waals_gewest",
"street": "Avenue Einstein",
"country": "BE",
"postcode": "1300",
"box_number": null,
"street_number": "14",
"locality_suffix": null
},
"old_address": {
"raw": "Chemin du Cyclotron 6, 1348 Louvain-La-Neuve",
"city": "Louvain-La-Neuve",
"region": "waals_gewest",
"street": "Chemin du Cyclotron",
"country": "BE",
"postcode": "1348",
"box_number": null,
"street_number": "6",
"locality_suffix": null
},
"effective_date": "2023-10-31",
"evidence_quote": "",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "absolute",
"statutaire_vs_werkelijke": "beide",
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "mixed",
"pub_date": "2023-12-05",
"filing_date": "2023-11-02",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "enig_aandeelhouder_schriftelijk",
"date": "2023-11-19",
"unanimous": true
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "Syndesi Therapeutics",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Nathalie Boonen",
"org_rep_person_name": null,
"person_role_at_subject": "Mandataire sp\u00E9cial"
},
"co_filed_documents": [
"formulaires I et Il"
]
}05-12-2023 Zetelverplaatsing van Louvain-La-Neuve naar Wavre
- Chemin du Cyclotron 6, 1348 Louvain-La-Neuve → Avenue Einstein 14, 1300 Wavre
Technische details
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "statutaire",
"new_address": {
"city": "Wavre",
"region": "Waals",
"street": "Avenue Einstein",
"country": "BE",
"postcode": "1300",
"box_number": null,
"street_number": "14"
},
"old_address": {
"city": "Louvain-La-Neuve",
"region": "Waals",
"street": "Chemin du Cyclotron",
"country": "BE",
"postcode": "1348",
"box_number": null,
"street_number": "6"
},
"effective_date": "2023-10-31",
"evidence_quote": "II ressort des r\u00E9solutions unanimes \u00E9crites des administrateurs en date du 19 novembre 2023 que les administrateurs ont d\u00E9cid\u00E9 de transf\u00E9rer le si\u00E8ge de la Soci\u00E9t\u00E9 et le si\u00E8ge d\u0027exploitation de Chemin du Cyclotron 6 1348 Louvain-La-Neuve \u00E0 Avenue Einstein 14, 1300 Wavre et ceci \u00E0 partir du 31 octobre 2023"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "SYNDESI THERAPEUTICS",
"legal_form": "SA"
}
}03-01-2023 1 bestuurder benoemd, 1 ontslagnemend
- Scott Reents — Bestuurder
- Robert Michael — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Robert Michael",
"address": null,
"birth_date": null
},
"effective_date": "2022-12-01",
"evidence_quote": "L\u0027actionnaire unique a pris connaissance de la demande de Monsieur Robert Michael d\u0027\u00EAtre d\u00E9charg\u00E9 de sa fonction d\u0027administrateur de la soci\u00E9t\u00E9 \u00E0 partir du 1er d\u00E9cembre 2022. L\u0027actionnaire unique accepte sa d\u00E9mission.",
"discharge_granted": true
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Scott Reents",
"address": null,
"birth_date": null
},
"effective_date": "2022-12-01",
"evidence_quote": "En vue de remplacer Monsieur Robert Michael, l\u0027actionnaire unique a d\u00E9cid\u00E9 de nommer Monsieur Scott Reents, \u00E9lisant domicile au si\u00E8ge de la soci\u00E9t\u00E9, comme nouvel administrateur de la soci\u00E9t\u00E9 \u00E0 partir du 1er d\u00E9cembre 2022."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "SYNDESI THERAPEUTICS",
"legal_form": "SA"
}
}03-01-2023 1 bestuurder benoemd, 1 ontslagnemend
- Scott Reents — Bestuurder
- Robert Michael — Bestuurder
Technische details
{
"events": [
{
"kind": "decharge_granted",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Robert Michael",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": false,
"effective_date": "2022-12-01",
"evidence_quote": "L\u0027actionnaire unique a pris connaissance de la demande de Monsieur Robert Michael d\u0027\u00EAtre d\u00E9charg\u00E9 de sa fonction d\u0027administrateur de la soci\u00E9t\u00E9 \u00E0 partir du 1er d\u00E9cembre 2022.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Robert Michael",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": false,
"effective_date": "2022-12-01",
"evidence_quote": "L\u0027actionnaire unique accepte sa d\u00E9mission.",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Scott Reents",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": "statutair",
"compensated": false,
"effective_date": "2022-12-01",
"evidence_quote": "En vue de remplacer Monsieur Robert Michael, l\u0027actionnaire unique a d\u00E9cid\u00E9 de nommer Monsieur Scott Reents, \u00E9lisant domicile au si\u00E8ge de la soci\u00E9t\u00E9, comme nouvel administrateur de la soci\u00E9t\u00E9 \u00E0 partir du 1er d\u00E9cembre 2022.",
"decharge_status": null,
"mandate_duration": {
"kind": "until_agm_year",
"value": "2027"
},
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": "Robert Michael",
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Nathalie Boonen",
"address": null,
"birth_date": null,
"profession": "employ\u00E9e",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "PwC Business Advisory Services BV",
"address": "Generaal Lemanstraat 67, 2018 Anvers",
"country": "BE",
"legal_form": "BV"
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027actionnaire unique a d\u00E9cid\u00E9 de charger Nathalie Boonen et/ou Inge Boets, employ\u00E9es de PwC Business Advisory Services BV, avec si\u00E8ge administratif \u00E0 Generaal Lemanstraat 67, 2018 Anvers, chacune agissant individuellement, de la signature et du d\u00E9p\u00F4t des formulaires I et II afin de publier les d\u00E9cis",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Inge Boets",
"address": null,
"birth_date": null,
"profession": "employ\u00E9e",
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": {
"kbo": null,
"name": "PwC Business Advisory Services BV",
"address": "Generaal Lemanstraat 67, 2018 Anvers",
"country": "BE",
"legal_form": "BV"
},
"statutory": "statutair",
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027actionnaire unique a d\u00E9cid\u00E9 de charger Nathalie Boonen et/ou Inge Boets, employ\u00E9es de PwC Business Advisory Services BV, avec si\u00E8ge administratif \u00E0 Generaal Lemanstraat 67, 2018 Anvers, chacune agissant individuellement, de la signature et du d\u00E9p\u00F4t des formulaires I et II afin de publier les d\u00E9cis",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "nl",
"pub_date": null,
"filing_date": "2022-12-05",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "enig_aandeelhouder_schriftelijk",
"date": "2022-12-05",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0686.599.355",
"name_full": "Syndesi Therapeutics",
"legal_form": "Soci\u00E9t\u00E9 anonyme"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Nathalie Boonen",
"org_rep_person_name": null,
"person_role_at_subject": "Mandataire sp\u00E9cial"
},
"co_filed_documents": [],
"corrected_publication_numac": null
}03-01-2023 1 bestuurder benoemd, 1 ontslagnemend
- Scott Reents — Bestuurder
- Robert Michael — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Robert Michael",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrateur",
"person": {
"rrn": null,
"name": "Scott Reents",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "Syndesi Therapeutics"
}
}17-03-2022 Wijziging in het bestuur
Technische details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "SYNDESI THERAPEUTICS",
"legal_form": "SA"
}
}17-03-2022 Jonathan Savidge neemt ontslag als dagelijks bestuur
- Jonathan Savidge — Dagelijks bestuur
Technische details
{
"events": [
{
"kind": "director_out",
"role": "d\u00E9l\u00E9gu\u00E9 \u00E0 la gestion journali\u00E8re",
"person": {
"rrn": null,
"name": "Jonathan Savidge",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "Syndesi Therapeutics"
}
}10-03-2022 3 bestuurders benoemd, 7 ontslagnemend
- Jean-Antoine de Los Frailes — Administrator
- Renaud Jean-Louis Benjamin Decroix — Administrator
- Robert Michael — Administrator
- Jean Combalbert — Administrator
- Roy Ervin Twyman — Administrator
- Morten Graugaard Døssing — Administrator
- Aidan King — Administrator
- Emmanuel Lacroix — Administrator
Technische details
{
"events": [
{
"kind": "director_out",
"role": "administrator",
"person": {
"rrn": null,
"name": "Jean Combalbert",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrator",
"person": {
"rrn": null,
"name": "Roy Ervin Twyman",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrator",
"person": {
"rrn": null,
"name": "Morten Graugaard D\u00F8ssing",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrator",
"person": {
"rrn": null,
"name": "Aidan King",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrator",
"person": {
"rrn": null,
"name": "Emmanuel Lacroix",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrator",
"person": {
"rrn": null,
"name": "Fiona Maclaughlin",
"address": null,
"birth_date": null
}
},
{
"kind": "director_out",
"role": "administrator",
"person": {
"rrn": null,
"name": "Christina Takke",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrator",
"person": {
"rrn": null,
"name": "Jean-Antoine de Los Frailes",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrator",
"person": {
"rrn": null,
"name": "Renaud Jean-Louis Benjamin Decroix",
"address": null,
"birth_date": null
}
},
{
"kind": "director_in",
"role": "administrator",
"person": {
"rrn": null,
"name": "Robert Michael",
"address": null,
"birth_date": null
}
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "Syndesi Therapeutics"
}
}10-03-2022 3 bestuurders benoemd, 7 ontslagnemend
- Jean-Antoine de Los Frailes — Bestuurder
- Renaud Jean-Louis Benjamin Decroix — Bestuurder
- Robert Michael — Bestuurder
- Jean Combalbert — Bestuurder
- Roy Ervin Twyman — Bestuurder
- Morten Graugaard Døssing — Bestuurder
- Aidan King — Bestuurder
- Emmanuel Lacroix — Bestuurder
Technische details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jean Combalbert",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0686599355",
"name": "JCO Consulting SRL",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2022-02-25",
"evidence_quote": "PAR CONS\u00C9QUENT, IL EST R\u00C9SOLU d\u0027accuser r\u00E9ception de la lettre de d\u00E9mission et d\u0027accepter la d\u00E9mission en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat, de chacun d\u0027entre eux: (a) JCO Consulting SRL, repr\u00E9sent\u00E9e de mani\u00E8re permanente par M. Jean Combalbert;"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Roy Ervin Twyman",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": "0686599355",
"name": "Amron Neuroscience LLC",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2022-02-25",
"evidence_quote": "PAR CONS\u00C9QUENT, IL EST R\u00C9SOLU d\u0027accuser r\u00E9ception de la lettre de d\u00E9mission et d\u0027accepter la d\u00E9mission en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat, de chacun d\u0027entre eux: (b) Amron Neuroscience LLC, repr\u00E9sent\u00E9e de mani\u00E8re permanente M. Roy Ervin Twyman;"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Morten Graugaard D\u00F8ssing",
"address": null,
"birth_date": null
},
"effective_date": "2022-02-25",
"evidence_quote": "PAR CONS\u00C9QUENT, IL EST R\u00C9SOLU d\u0027accuser r\u00E9ception de la lettre de d\u00E9mission et d\u0027accepter la d\u00E9mission en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat, de chacun d\u0027entre eux: (c) M. Morten Graugaard D\u00F8ssing;"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Aidan King",
"address": null,
"birth_date": null
},
"effective_date": "2022-02-25",
"evidence_quote": "PAR CONS\u00C9QUENT, IL EST R\u00C9SOLU d\u0027accuser r\u00E9ception de la lettre de d\u00E9mission et d\u0027accepter la d\u00E9mission en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat, de chacun d\u0027entre eux: (d) M. Aidan King;"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Emmanuel Lacroix",
"address": null,
"birth_date": null
},
"effective_date": "2022-02-25",
"evidence_quote": "PAR CONS\u00C9QUENT, IL EST R\u00C9SOLU d\u0027accuser r\u00E9ception de la lettre de d\u00E9mission et d\u0027accepter la d\u00E9mission en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat, de chacun d\u0027entre eux: (e) M. Emmanuel Lacroix;"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Fiona Maclaughlin",
"address": null,
"birth_date": null
},
"effective_date": "2022-02-25",
"evidence_quote": "PAR CONS\u00C9QUENT, IL EST R\u00C9SOLU d\u0027accuser r\u00E9ception de la lettre de d\u00E9mission et d\u0027accepter la d\u00E9mission en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat, de chacun d\u0027entre eux: (f) Mme Fiona Maclaughlin (n\u00E9e Mash);"
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Christina Takke",
"address": null,
"birth_date": null
},
"effective_date": "2022-02-25",
"evidence_quote": "PAR CONS\u00C9QUENT, IL EST R\u00C9SOLU d\u0027accuser r\u00E9ception de la lettre de d\u00E9mission et d\u0027accepter la d\u00E9mission en tant qu\u0027administrateur de la Soci\u00E9t\u00E9, avec effet imm\u00E9diat, de chacun d\u0027entre eux: (g) Mme Christina Takke."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jean-Antoine de Los Frailes",
"address": null,
"birth_date": null
},
"effective_date": "2022-02-25",
"evidence_quote": "IL EST EN OUTRE R\u00C9SOLU de nommer, avec effet imm\u00E9diat, comme administrateurs de la Soci\u00E9t\u00E9 qui exerceront leurs fonctions conform\u00E9ment aux statuts de la Soci\u00E9t\u00E9, jusqu\u0027\u00E0 la premi\u00E8re des deux dates suivantes: (a) le sixi\u00E8me anniversaire du pr\u00E9sent consentement \u00E9crit unanime, ou (b) leur d\u00E9mission ou "
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Renaud Jean-Louis Benjamin Decroix",
"address": null,
"birth_date": null
},
"effective_date": "2022-02-25",
"evidence_quote": "IL EST EN OUTRE R\u00C9SOLU de nommer, avec effet imm\u00E9diat, comme administrateurs de la Soci\u00E9t\u00E9 qui exerceront leurs fonctions conform\u00E9ment aux statuts de la Soci\u00E9t\u00E9, jusqu\u0027\u00E0 la premi\u00E8re des deux dates suivantes: (a) le sixi\u00E8me anniversaire du pr\u00E9sent consentement \u00E9crit unanime, ou (b) leur d\u00E9mission ou "
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Robert Michael",
"address": null,
"birth_date": null
},
"effective_date": "2022-02-25",
"evidence_quote": "IL EST EN OUTRE R\u00C9SOLU de nommer, avec effet imm\u00E9diat, comme administrateurs de la Soci\u00E9t\u00E9 qui exerceront leurs fonctions conform\u00E9ment aux statuts de la Soci\u00E9t\u00E9, jusqu\u0027\u00E0 la premi\u00E8re des deux dates suivantes: (a) le sixi\u00E8me anniversaire du pr\u00E9sent consentement \u00E9crit unanime, ou (b) leur d\u00E9mission ou "
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "SYNDESI THERAPEUTICS",
"legal_form": "SA"
}
}07-03-2022 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": true
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "SYNDESI THERAPEUTICS"
},
"legal_form_change": {
"new": "Soci\u00E9t\u00E9 anonyme",
"old": "Soci\u00E9t\u00E9 anonyme",
"changed": false
}
}07-03-2022 Verrichting in kapitaal of aandelen
Technische details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "SYNDESI THERAPEUTICS"
}
}07-03-2022 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": true,
"effective_date": "2022-02-25",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0686.599.355",
"name_full": "SYNDESI THERAPEUTICS",
"legal_form": "SA"
},
"signature_regime": "solo",
"special_mandates": [
{
"quote": "une autorisation sp\u00E9ciale \u00E0 M. Axel Baet\u00E9, M. Toon Dictus et Mme Talitha Crabbe et \u00E0 chaque autre collaborateur ou assistant juridique de Cleary Gottlieb Steen \u0026 Hamilton LLP, \u00E9lisant domicile \u00E0 leur adresse professionnelle situ\u00E9e Rue de la Loi 57, 1040 Bruxelles, Belgique, chacun agissant seul et avec pouvoir de substitution, pour refl\u00E9ter les d\u00E9cisions prises par l\u0027assembl\u00E9e des actionnaires dans le registre des actionnaires et, dans la mesure requise, le registre des droits de souscription de la soci\u00E9t\u00E9 ainsi qu\u0027aupr\u00E8s de toutes les autorit\u00E9s fiscales, y compris en mati\u00E8re de \u0022 TVA \u0022, ainsi qu\u0027aupr\u00E8s du greffe du tribunal de l\u0027entreprise, de m\u00EAme qu\u0027aupr\u00E8s d\u0027un ou plusieurs guichets d\u0027affaires reconnus, afin d\u0027accomplir tous les actes, faire les d\u00E9clarations, signer et d\u00E9poser les documents requis pour l\u0027enregistrement, la signature et le d\u00E9p\u00F4t des documents n\u00E9cessaires \u00E0 l\u0027inscription, la modification ou la radiation de l\u0027inscription de la soci\u00E9t\u00E9 aupr\u00E8s de la Banque-Carrefour des Entreprises, et de mani\u00E8re g\u00E9n\u00E9rale, faire tout ce qui est n\u00E9cessaire ou utile \u00E0 l\u0027accomplissement de ces t\u00E2ches",
"holder_kbo": null,
"holder_name": "Cleary Gottlieb Steen \u0026 Hamilton LLP",
"scope_categories": [
"KBO",
"tax",
"filing",
"publication"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}07-03-2022 Kapitaalverhoging van €26.765.010,40 tot €26.765.010,40
Technische details
{
"events": [
{
"kind": "capital_increase",
"amount": 26765010.4,
"currency": "EUR",
"after_eur": 26765010.4,
"delta_eur": 26765010.4,
"before_eur": null,
"amount_type": "kapitaal_effectief",
"effective_date": "2022-02-25",
"evidence_quote": "Le capital est fix\u00E9 \u00E0 vingt-six millions sept cent soixante-cinq mille dix euros quarante cents (\u20AC 26.765.010,40).",
"contribution_type": "cash"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "SYNDESI THERAPEUTICS",
"legal_form": "SA"
}
}07-03-2022 Verrichting in kapitaal of aandelen
Technische details
{
"events": [],
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "BERQUIN NOTAIRES",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2022-03-07",
"filing_date": "2022-03-03",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2022-02-25",
"unanimous": null,
"under_authorized_capital": true,
"underlying_resolution_date": null
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0686.599.355",
"name_full": "SYNDESI THERAPEUTICS",
"legal_form": "SA",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Peter VAN MELKEBEKE",
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition du proc\u00E8s-verbal",
"rapport du conseil d\u0027administration",
"texte coordonn\u00E9 des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 4391665,
"class_name": "Ordinaires",
"capital_share_eur": 26765010.4,
"voting_rights_per_share": 1.0
},
{
"n_shares": 9,
"class_name": "Cat\u00E9gorie A",
"capital_share_eur": 0.0,
"voting_rights_per_share": 0.0
}
]
}07-03-2022 Publicatie in het Belgisch Staatsblad — Diversen
Technische details
{
"stage": null,
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "BERQUIN NOTAIRES",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2022-03-07",
"filing_date": "2022-03-03",
"act_kind_objet": "CAPITAL, ACTIONS, STATUTS (TRADUCTION, COORDINATION,"
},
"decision": {
"body": "bijzondere_algemene_vergadering",
"act_date": "2022-02-25",
"unanimous": null
},
"conversion": null,
"detected_kind": "other",
"report_waiver": null,
"restructuring": {
"parties": [
{
"kbo": "0686.599.355",
"name": "SYNDESI THERAPEUTICS",
"role": "other",
"address": "Chemin du Cyclotron 6, 1348 Ottignies-Louvain-la-Neuve",
"is_foreign": false,
"legal_form": "SA",
"is_new_company": false,
"jurisdiction_country": null
}
],
"exchange_ratio": null,
"legal_articles": [],
"is_cross_border": false,
"is_silent_merger": false,
"balance_basis_date": null,
"exchange_ratio_text": null,
"new_shares_issued_n": 0,
"real_estate_included": false,
"patrimony_description": "Aucun transfert de patrimoine n\u0027est effectu\u00E9. Les modifications portent uniquement sur la structure des actions (reclassement des actions de cat\u00E9gorie A en actions ordinaires, renum\u00E9rotation des actions, modification des droits attach\u00E9s aux classes d\u0027actions).",
"equity_transferred_eur": null,
"accounting_effective_date": null
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "SYNDESI THERAPEUTICS",
"legal_form": "SA"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Peter VAN MELKEBEKE",
"org_rep_person_name": null
},
"summary_narrative": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale extraordinaire de la soci\u00E9t\u00E9 anonyme SYNDESI THERAPEUTICS a d\u00E9cid\u00E9 de modifier les statuts de la soci\u00E9t\u00E9, notamment en reclasseant les actions de la Cat\u00E9gorie A en actions ordinaires, en renum\u00E9rotant toutes les actions existantes, et en modifiant les droits attach\u00E9s aux diff\u00E9rentes classes d\u0027actions. Ces modifications ont \u00E9t\u00E9 adopt\u00E9es avec effet imm\u00E9diat.",
"co_filed_documents": [
"une exp\u00E9dition du proc\u00E8s-verbal",
"un rapport du conseil d\u0027administration \u00E9tabli conform\u00E9ment \u00E0 l\u0027article 7:155 du CSA",
"le texte coordonn\u00E9 des statuts"
],
"detected_real_type": "other",
"referenced_correction": null,
"should_reroute_to_category": "statutes"
}03-03-2022 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2022-02-25",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0686.599.355",
"name_full": "SYNDESI THERAPEUTICS",
"legal_form": "SA"
},
"signature_regime": null,
"special_mandates": [
{
"quote": "Tous pouvoirs sont conf\u00E9r\u00E9s \u00E0 Christoph Michiels, Henri-Simon Vande Vyver, Jacques Bakulu et tout autre collaborateur de Deloitte Legal - Lawyers \u00E9lisant domicile dans le cadre du pr\u00E9sent acte \u00E0 Gateway Building, Luchthaven-Brussel-Nationaal 1J, 1930 Zaventem et \u00E0 chaque administrateur, afin de (i) supprimer les droits de souscription exerc\u00E9es du registre de droits de souscription, et (ii) inscrire les actions \u00E9mises suite \u00E0 l\u0027exercice de droits de souscription dans le registre des actions et de signer ce registre pour le compte des actionnaires en question.",
"holder_kbo": null,
"holder_name": "Deloitte Legal - Lawyers",
"scope_categories": [
"filing",
"register_maintenance"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}03-03-2022 Herstructurering van de aandelenklassen
Technische details
{
"events": [
{
"kind": "share_class_creation",
"after_eur": 26765010.4,
"delta_eur": 2542410.57,
"before_eur": 24222599.83,
"share_emission": {
"agio_eur": 2542410.57,
"share_form": "no_nominal_value",
"share_class": "Ordinaire",
"n_new_shares": 381171,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 6.67
},
"decrease_purpose": null,
"contribution_type": "geld",
"paid_up_delta_eur": 2542410.57,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "Berquin Notaires",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2022-03-03",
"filing_date": "2022-03-01",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "enig_aandeelhouder_schriftelijk",
"act_date": "2022-02-25",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": false,
"firm_kbo": null,
"firm_name": "Deloitte Legal",
"ibr_number": null,
"mission_type": "partial_split",
"individual_name": "Christoph Michiels"
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "SYNDESI THERAPEUTICS",
"legal_form": "Soci\u00E9t\u00E9 anonyme",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Peter VAN MELKEBEKE",
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition de l\u0027acte",
"procuration",
"texte coordonn\u00E9 des statuts"
],
"shareholders_after": [],
"share_classes_after": [
{
"n_shares": 4010503,
"class_name": "Cat\u00E9gorie A",
"capital_share_eur": null,
"voting_rights_per_share": null
},
{
"n_shares": 381171,
"class_name": "Ordinaire",
"capital_share_eur": null,
"voting_rights_per_share": null
}
]
}03-03-2022 Statutenwijziging
Technische details
{
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"name_change": {
"new": "",
"old": "",
"changed": false
},
"seat_change": {
"changed": false
},
"object_change": {
"changed": false
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "SYNDESI THERAPEUTICS"
},
"legal_form_change": {
"new": "Soci\u00E9t\u00E9 anonyme",
"old": "Soci\u00E9t\u00E9 anonyme",
"changed": false
}
}03-03-2022 Kapitaalverhoging van €2.542.410,57 tot €26.765.010,40
- €24.222.599,83 → €26.765.010,40
- Inbreng in geld · Apport en numéraire
Technische details
{
"events": [
{
"kind": "capital_increase",
"after_eur": 26765010.4,
"delta_eur": 2542410.5700000003,
"before_eur": 24222599.83,
"contribution_type": "geld"
}
],
"schema": "v3.2",
"act_meta": {
"extractor": "qwen3-30b-a3b"
},
"subject_company": {
"kbo": "0686.599.355",
"name_full": "SYNDESI THERAPEUTICS"
}
}Genereer een gestructureerde, feitelijke nota op basis van alle signalen in dit dossier: risico, financiële gezondheid, eigendomsstructuur, mandaten en sectorvergelijking.
| Officiële naamFR | SYNDESI THERAPEUTICS |